Treasurer of the State of North Carolina’s Acadia Pharmaceuticals ACAD Stock Holding History

Treasurer of the State of North Carolina’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-40,580	Closed	-$1.05M	–	1034
2021 Q1	$1.05M	Sell	40,580 -100	-0.2%	-$4.4K	0.01%	952
2020 Q4	$2.17M	Buy	40,680 +90	+0.2%	+$4.47K	0.01%	731
2020 Q3	$1.67M	Buy	40,590 +440	+1%	+$19K	0.01%	748
2020 Q2	$1.95M	Buy	+40,150	New	+$1.93M	0.02%	691
2018 Q2	–	Sell	-9,138	Closed	-$205K	–	983
2018 Q1	$205K	Buy	+9,138	New	+$253K	0.01%	950

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Treasurer of the State of North Carolina's ACAD Position: Q2 2021 in Review

Treasurer of the State of North Carolina sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 40,580 shares — an estimated $1.05M sold.

Treasurer of the State of North Carolina first reported a position in ACAD in Q1 2018 and held it in 5 quarters. The position peaked at $2.17M in Q4 2020. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

Treasurer of the State of North Carolina reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Treasurer of the State of North Carolina sold 40,580 Acadia Pharmaceuticals shares in Q2 2021, an estimated $1.05M.
Treasurer of the State of North Carolina first reported a position in Acadia Pharmaceuticals in Q1 2018 and held it in 5 quarters.
Treasurer of the State of North Carolina's Acadia Pharmaceuticals position peaked at $2.17M in Q4 2020.
245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2021, filed 13 Aug 2021.